BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20502879)

  • 1. Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model.
    Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Kenmochi S; Shimamoto K; Harada T; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Feb; 85(2):155-62. PubMed ID: 20502879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular expression analysis of beta-naphthoflavone-induced hepatocellular tumors in rats.
    Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Harada T; Shibutani M; Mitsumori K
    Toxicol Pathol; 2009 Jun; 37(4):446-55. PubMed ID: 19389873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of oxidative stress in hepatocellular tumor-promoting activity of oxfendazole in rats.
    Dewa Y; Nishimura J; Muguruma M; Jin M; Kawai M; Saegusa Y; Okamura T; Umemura T; Mitsumori K
    Arch Toxicol; 2009 May; 83(5):503-11. PubMed ID: 18754104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-3-carbinol enhances oxidative stress responses resulting in the induction of preneoplastic liver cell lesions in partially hepatectomized rats initiated with diethylnitrosamine.
    Shimamoto K; Dewa Y; Ishii Y; Kemmochi S; Taniai E; Hayashi H; Imaoka M; Morita R; Kuwata K; Suzuki K; Shibutani M; Mitsumori K
    Toxicology; 2011 May; 283(2-3):109-17. PubMed ID: 21396975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
    Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
    Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats.
    Nishimura J; Saegusa Y; Dewa Y; Jin M; Kawai M; Kemmochi S; Harada T; Hayashi SM; Shibutani M; Mitsumori K
    Arch Toxicol; 2010 Feb; 84(2):143-53. PubMed ID: 20033131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Jin M; Saegusa Y; Kawai M; Umemura T; Shibutani M; Mitsumori K
    Toxicol Sci; 2008 Dec; 106(2):339-49. PubMed ID: 18775883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
    Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
    Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
    Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting potential of a Jamaica quassia extract in a rat medium-term hepatocarcinogenesis bioassay.
    Woo GH; Shibutani M; Inoue K; Fujimoto H; Takahashi M; Lee KY; Hirose M
    Food Chem Toxicol; 2007 Jul; 45(7):1160-4. PubMed ID: 17306917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analyses of the liver in rats treated with oxfendazole.
    Dewa Y; Nishimura J; Muguruma M; Matsumoto S; Takahashi M; Jin M; Mitsumori K
    Arch Toxicol; 2007 Sep; 81(9):647-54. PubMed ID: 17340121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between CYP1A induction by indole-3-carbinol or flutamide and liver tumor-promoting potential in rats.
    Shimamoto K; Dewa Y; Kemmochi S; Taniai E; Hayashi H; Imaoka M; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Sep; 85(9):1159-66. PubMed ID: 21203749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-carcinogenic effect of cyclohexanol on the development of preneoplastic lesions in a rat hepatocarcinogenesis model.
    Márquez-Rosado L; Trejo-Solís C; Cabrales-Romero Mdel P; Arce-Popoca E; Sierra-Santoyo A; Alemán-Lazarini L; Fatel-Fazenda S; Carrasco-Legleu CE; Villa-Treviño S
    Mol Carcinog; 2007 Jul; 46(7):524-33. PubMed ID: 17393424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
    Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.